Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Boracchi

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|July 4, 1998
Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-upF A Mauri, O Caffo, S Veronese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancerG Gasparini, M Barbareschi, C Doglioni, et al.
Breast Cancer Research and Treatment|June 1, 1997
Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extensionL Mariani, D Coradini, E Biganzoli, et al.
Genus|January 1, 1986
Cigarette smoking in pregnancy: relationship to perinatal outcomes in six Italian centresA De Scrilli, P Boracchi, G Pardi, et al.
International Journal of Cancer|June 21, 1996
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasG Gasparini, E Bonoldi, G Viale, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical studyG Gasparini, W J Gullick, S Maluta, et al.
Computers in Biology and Medicine|December 23, 2006
Double-blind evaluation and benchmarking of survival models in a multi-centre studyA Taktak, L Antolini, M Aung, et al.
Tumori|June 11, 1999
Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in childrenR Luksch, G Sampietro, P Collini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapyP Pelosio, M Barbareschi, E Bonoldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|July 4, 1998
Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-upF A Mauri, O Caffo, S Veronese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancerG Gasparini, M Barbareschi, C Doglioni, et al.
Breast Cancer Research and Treatment|June 1, 1997
Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extensionL Mariani, D Coradini, E Biganzoli, et al.
Genus|January 1, 1986
Cigarette smoking in pregnancy: relationship to perinatal outcomes in six Italian centresA De Scrilli, P Boracchi, G Pardi, et al.
International Journal of Cancer|June 21, 1996
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasG Gasparini, E Bonoldi, G Viale, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical studyG Gasparini, W J Gullick, S Maluta, et al.
Computers in Biology and Medicine|December 23, 2006
Double-blind evaluation and benchmarking of survival models in a multi-centre studyA Taktak, L Antolini, M Aung, et al.
Tumori|June 11, 1999
Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in childrenR Luksch, G Sampietro, P Collini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapyP Pelosio, M Barbareschi, E Bonoldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.
Pageof 12